SAGGESE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 37.444
EU - Europa 17.792
AS - Asia 7.477
AF - Africa 217
SA - Sud America 192
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 17
Totale 63.184
Nazione #
US - Stati Uniti d'America 27.065
CA - Canada 10.357
IT - Italia 6.041
CN - Cina 4.328
SE - Svezia 2.305
PL - Polonia 1.835
BG - Bulgaria 1.747
UA - Ucraina 1.726
SG - Singapore 1.196
DE - Germania 1.170
TR - Turchia 916
FI - Finlandia 719
CH - Svizzera 718
GB - Regno Unito 687
VN - Vietnam 621
RU - Federazione Russa 338
HK - Hong Kong 204
FR - Francia 172
BR - Brasile 151
SN - Senegal 119
IN - India 77
BE - Belgio 66
CI - Costa d'Avorio 42
AT - Austria 39
AU - Australia 38
ES - Italia 30
BJ - Benin 29
JP - Giappone 29
NL - Olanda 27
GR - Grecia 23
LV - Lettonia 23
RO - Romania 22
KR - Corea 21
IE - Irlanda 20
IL - Israele 20
EE - Estonia 16
EU - Europa 16
MX - Messico 16
CZ - Repubblica Ceca 10
HU - Ungheria 9
AR - Argentina 8
CL - Cile 8
EG - Egitto 8
KZ - Kazakistan 8
PT - Portogallo 8
NZ - Nuova Zelanda 7
TH - Thailandia 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
DK - Danimarca 6
PE - Perù 6
RS - Serbia 6
ID - Indonesia 5
IR - Iran 5
LT - Lituania 4
NG - Nigeria 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
ZA - Sudafrica 4
AL - Albania 3
DZ - Algeria 3
EC - Ecuador 3
HR - Croazia 3
IQ - Iraq 3
LU - Lussemburgo 3
MD - Moldavia 3
MY - Malesia 3
NO - Norvegia 3
BD - Bangladesh 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
IS - Islanda 2
KE - Kenya 2
LB - Libano 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CR - Costa Rica 1
FK - Isole Falkland (Malvinas) 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
LK - Sri Lanka 1
MA - Marocco 1
ME - Montenegro 1
MM - Myanmar 1
MN - Mongolia 1
PY - Paraguay 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 63.183
Città #
Montreal 9.197
Woodbridge 3.233
Chandler 2.815
Ann Arbor 2.700
Milan 2.427
Jacksonville 2.295
Houston 1.869
Sofia 1.747
Fairfield 1.447
Shanghai 1.169
Ottawa 1.113
Ashburn 1.050
New York 963
Beijing 957
Santa Clara 955
Princeton 769
Singapore 723
Bern 701
Boardman 690
Wilmington 674
Nanjing 665
Seattle 657
Lawrence 654
Izmir 633
Cambridge 494
Medford 479
Des Moines 473
Dearborn 444
Jüchen 440
Dong Ket 292
Nanchang 277
Istanbul 250
Rome 203
Hong Kong 187
Boulder 165
Redwood City 161
Kunming 151
San Diego 125
Dakar 119
Florence 114
Shenyang 109
Hebei 96
Changsha 90
Tianjin 84
Ogden 82
Norwalk 78
Jiaxing 77
Hefei 73
Lancaster 71
Orange 71
Verona 68
Los Angeles 66
Düsseldorf 63
Falls Church 61
Brussels 60
Detroit 56
Frankfurt am Main 56
Serra 51
Hangzhou 49
London 46
Guangzhou 44
Pune 44
Washington 43
Abidjan 42
Chicago 39
Lanzhou 39
Auburn Hills 37
San Francisco 35
Vienna 34
Toronto 33
Bologna 31
Pisa 30
Changchun 29
Cotonou 29
Fuzhou 29
Jinan 26
Tokyo 24
Dallas 23
Helsinki 23
Palermo 22
Quanzhou 22
Alessandria 19
Bremen 19
Naples 19
Phoenix 18
Greifswald 17
Chengdu 16
Edinburgh 16
Lucca 16
Tallinn 16
Beaumont 15
Council Bluffs 15
Kocaeli 15
Costa Mesa 14
Madrid 14
Dublin 12
Melbourne 12
Ningbo 12
Seoul 12
São Paulo 12
Totale 46.851
Nome #
Fotoderivati del 7-deidrocolesterolo e della Vitamina D dopo esposizione solare. Dati preliminari 3.384
Growth delay in renal hypophosphatemic rickets. Effects of 1,25(oh)2D3 at supraphysiological doses 3.140
Terapia con ormone della crescita in età pediatrica. Importanza delle dosi nelle varie indicazioni 2.485
Blockade of growth hormone secretion with an anticholinergic substance in short children 2.451
Central precocious puberty: Short-term comparative data of treatment with monthly or long-acting three months depot triptorelin 219
Densitometria ossea in età pediatrica. Valori normali tra 2 e 19 anni. Primi dati italiani. 187
Ottimizzazione della terapia con ormone della crescita nel bambino con deficit di GH 180
L'iperfosfatasemia infantile transitoria:considerazioni etiopatogenetiche sulla base di osservazioni personali 175
Livelli normali di osteocalcina in età pediatrica. Comparazione con la mineralizzazione ossea e con le variazioni fisiologiche dei livelli di 1,25-diidrossivitamina D 163
Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH Research Society (Reprinted from J Clin Endocrinol Metab, vol 85, pg 3990-3993, 2000) 163
How do environmental estrogen disruptors induce precocious puberty? 163
Sex steroids and the acquisition of bone mass 162
Bone mineral density and biochemical parameters of bone turnover in children with growth hormone deficiency 158
Malattia granulomatosa cronica. Effetti del cotrimoxazolo e della vitamina C sull'attività battericida e chemiotattica dei leucociti 155
Bone mineralization and calciotropic hormones in children with hyperthyroidism - effects of methimazole therapy 154
Relationships of serum leptin levels with biochemical markers of bone turnover and with growth factors in normal weight and overweight children 151
Trattamento con ormone della crescita in età pediatrica. Importanza dell’aderenza alla terapia nelle varie indicazioni, con particolare riferimento alla sindrome di Turner 150
Osteoporosis in children and adolescents: Diagnosis, risk factors, and prevention 149
Criteria for recognition of the growth-inefficient child who may respond to treatment with growth-hormone 148
Ormoni calciotropi nell’osteoporosi dell’anoressia nervosa 146
Stimulated growth-hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty - relationship with peripheral plasma GH-releasing hormone and somatostatin levels 146
Prevalence of hypovitaminosis D and predictors of vitamin D status in Italian healthy adolescents 144
Parathyroid hormone-related protein in healthy pregnant-women 141
In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. 140
Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females 140
GROWTH HORMONE DEFICIENCY 140
Second European Conference - Diagnosis and treatment of central precocious puberty - Pisa, Italy, March 17-18, 2005 - Foreword 139
Immunoreactive parathyroid hormone and calcitonin in children's cerebrospinal fluid. 138
Mineral metabolism and calcitriol therapy in idiopathic juvenile osteoporosis 138
Mycoestrogen Pollution of Italian Infant Food 137
Lumbar bone mineral density at final height and prevalence of fractures in treated children with GH deficiency 136
Rachitismo ipofosfatemico familiare. Dati auxologici e mineralizzazione ossea dopo terapia con 1,25-diidrossi-Vitamina D3 135
From bone biology to bone analysis 135
GHRH-test in short children with "non classic" GH deficiency. A comparison with "classic" GH deficiency and short normal stature. 134
Short-term effect of testosterone treatment on reduced bone-density in boys with constitutional delay of puberty 134
Ketoconazole decreases the serum ionized calcium and 1,25-dihydroxyvitamin-D levels in tuberculosis-associated hypercalcemia 134
Magnesium-metabolism in diabetes-mellitus - reply 133
C-type natriuretic peptide plasma levels are reduced in obese adolescents. 133
17q12 Microduplications: A Challenge for Clinicians 132
Bone mineral density and biochemical parameters of bone turnover in children with growth hormone deficiency 131
Effect of gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty: Final height results 131
High risk of congenital hypothyroidism in multiple pregnancies 131
Idiopathic juvenile osteoporosis - evidence of normal osteoblast function by 1,25-dihydroxyvitamin-d3 stimulation test 131
The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass 130
Growth hormone treatment in renal hypophosphatemic rickets 129
La ialinosi sistemica infantile: caso clinico 128
Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders 128
High incidence of central precocious puberty in a bounded geographic area of northwest Tuscany: an estrogen disrupter epidemic? 128
Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty 127
Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities 127
A comparison between radiographic and sonographic assessment of hand and wrist bones for the estimation of skeletal age in the child patient., 127
Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines 127
Long-term outcome of male-limited gonadotropin-independent precocious puberty 125
Pubertal changes in biochemical markers of growth 125
Serum levels of carboxyterminal propeptide of type-i procollagen in healthy-children from 1st year of life to adulthood and in metabolic bone-diseases 124
Elevated calcitonin gene-related peptide in polycythemic newborn-infants 124
Hypomagnesemia and the parathyroid-hormone vitamin-d endocrine system in children with insulin-dependent diabetes-mellitus - effects of magnesium administration 124
Assessment of bone mineral status at phalanges of the hand by morphological analysis of ultrasound graphic trace 124
A case of Von Recklinghausen's neurofibromatosis with precocious puberty 123
Bone loss during gonadotropin-releasing-hormone agonist treatment in girls with true precocious puberty is not due to an impairment of calcitonin secretion 123
Combination treatment with growth-hormone and gonadotropin-releasing-hormone analogs in short normal girls 123
Chemical Biomarkers of Human Breast Milk Pollution. 123
Approccio diagnostico al pubarca prematuro: studio di 7 casi 122
Growth hormone treatment in non-classical GH deficient children 122
Anabolic growth rate of girls with precocious puberty exposed to estrogenic mycotoxins 122
Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. 122
Idiopathic juvenile osteoporosis 121
Vitamin-D receptor genotype does not predict bone mineral density, bone turnover, and growth in prepubertal children. 121
DSM-5 criteria for PTSD in parents of pediatric patients with epilepsy: What are the changes with respect to DSM-IV-TR? 121
Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency 120
Alterazioni strutturali della dentina in pazienti con rachitismo ipofosfatemico familiare. Effetti del trattamento 120
null 120
Bone demineralization in cystic fibrosis: Evidence of imbalance between bone formation and degradation 119
Altered bone mineral density in patients with complete androgen insensitivity syndrome. 119
Impiego del test dell’ipoglicemia insulino-indotta nella valutazione della secrezione somatotropinica nei bambini con deficit staturale. considerazioni su 325 casi 118
Puberta' precoce isosessuale 118
Determination of intact parathyrin by immunoradiometric assay evaluated in normal-children and in patients with various disorders of calcium-metabolism 118
Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty 118
Evaluation of l-thyroxine replacement therapy in children with congenital hypothyroidism 118
Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone 118
La disidratazione nel bambino 117
Comportamento della prolattina nei bambini con ritardo staturale 117
La nostra esperienza nel trattamento del nanismo ipofisario 116
Evaluation of a peptide family encoded by the calcitonin gene in selected healthy pregnant-women - a longitudinal-study 116
Combined therapy with gnRH agonists (gnRHA) and gh in short subjects without a GH deficiency and with a normal onset of puberty 116
Il neonato con genitali ambigui: la diagnosi differenziale dopo un anno di vita 116
La D è una nuova vitamina? 116
Administering 25-hydroxyvitamin D3 in vitamin D-deficient young type 1A diabetic patients reduces reactivity against islet autoantigens 116
Plasma zinc in short statured children 115
Association between x-linked hypophosphatemic rickets and klinefelters-syndrome - effects on growth and body proportion 115
Testosterone treatment and bone mineralization in constitutional delay of puberty 115
Perinatal care at an extremely low gestational age (22-25 weeks). An Italian approach: the "Carta di Firenze" 115
Human breast milk and xenoestrogen exposure: a possible impact on human health. 115
Puberty and bone development 115
Androgen-receptor blockade does not impair bone mineral density in adolescent females 114
Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency - Response 114
Effect of celiac disease and gluten-free diet on growth hormone-binding protein, insulin-like growth factor-I, and insulin-like growth factor-binding proteins 114
A Case of 22q11 Deletion Syndrome (22q11DS) with a Panayiotopoulos Epileptic Pattern: Are Additional Copy-Number Variations a Possible Second Hit in Modulating the 22q11DS Phenotype? 114
Sex steroidal targets & genetic susceptibility to idiopathic cryptorchidism 113
Thyroid outcome during long-term gonadotropin-releasing hormone agonist treatments for idiopathic precocious puberty 113
Totale 24.064
Categoria #
all - tutte 146.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.848 0 0 0 0 0 0 734 276 704 314 744 76
2020/20214.285 497 79 465 147 567 194 456 420 201 383 146 730
2021/20226.264 40 553 58 506 1.313 816 70 273 250 160 199 2.026
2022/20236.666 991 648 309 655 954 1.020 59 538 967 16 436 73
2023/202418.457 1.495 985 1.167 549 1.043 1.061 99 178 153 11.078 73 576
2024/20254.717 83 787 174 880 950 1.323 520 0 0 0 0 0
Totale 63.610